Review of regional measles surveillance data in the Americas, 1996-99

Lancet

Volumn 355, Issue 9219, 2000, Pages 1943-1948

  Hersh, Bradley S ^a   Tambini, Gina ^a   Nogueira, Ana Cristina ^a   Carrasco, Peter ^a   De Quadros, Ciro A ^a  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ARTICLE; BRAZIL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; PRIORITY JOURNAL; VIRUS TRANSMISSION; WESTERN HEMISPHERE;

EID: 0034600556     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02325-4     Document Type: Article

References (29)

1. Murray C.J., Lopez A.D. Mortality by cause for eight regions of the world. global burden of disease study Lancet. 349:1997;1269-1276.
2. Robbins F.C., de Quadros C.A. Certification of the eradication of indigenous transmission of wild polio virus in the Americas. J Infect Dis. 175:1997;281-285.
3. Galindo M.A., Santin M., Resik S.et al. The elimination of measles from Cuba. Pan Am J Public Health. 4:1998;171-177.
4. de Quadros C.A., Hersh B.S., Silveira C., Andrus J.M. Eradication of wild poliovirus from the Americas: acute flaccid paralysis surveillance, 1988-95. J Infect Dis. 175:1997;37-42.
5. Lievens A.W., Brunell P.A. Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles. J Clin Microbiol. 24:1986;391-394.
6. Ozanne G., D'Halewyn M.A. Performance and reliability of the Enzygnost measles enzyme-linked immunosorbent assay for detection of measles virus-specific immunoglobulin M antibody during a large measles epidemic. J Clin Microbiol. 30:1992;564-569.
7. Erdman D.D., Anderson L.J., Adams D.R., Stewart J.A., Markowitz L.E., Bellini W.J. Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specifici antibodies to measles virus. J Clin Microbiol. 29:1991;1461-1466.
8. Hummel K.B., Erdman D.D., Heath J., Bellini W.J. Baculovirus expression of the nucleoprotein gene of measles virus and the utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol. 30:1992;2874-2880.
9. Vitek C.R., Redd S.C., Redd S.B., Hadler S.C. Trends in importation of measles to the United States, 1986-1994. JAMA. 277:1997;1952-1956.
10. Measles-United States, 1997. MMWR CDC Surveill Summ. 47:1998;273-276.
11. Ferson M.J., Young L.C., Robertson P.W., Whybin L.R. Difficulties in the clinical diagnosis of measles. proposal for modified clinical case definition Med J Aust. 163:1995;364-366.
12. Ramsay M., Cohen B., Brown D. Serum IgM testing is needed in all cases of suspected measles (letter). BMJ. 313:1996;231.
13. Rota J.S., Heath J.L., Rota P.A.et al. Molecular epidemiology of measles virus. identification of pathways of transmission and implications for measles elimination J Infect Dis. 173:1996;32-37.
14. Helfand R.F., Kebede A., Alexander J.P.et al. Comparative detection of measles-specific IgM in oral fluid and serum from children by an antibody-capture IgM EIA. J Infect Dis. 173:1996;1470-1474.
15. Ramsay M., Brugha R., Brown D. Surveillance of measles in England and Wales. implications of national saliva testing programme Bull World Health Organ. 75:1997;515-521.
16. Oliveira S.A., Siqueira M.M., Brown D.W., Camacho L.A., Faillace T., Cohen B.J. Salivary diagnosis of measles for surveillance. a clinic-based study in Niteroi, state of Rio de Janeiro, Brazil Trans R Soc Trop Med Hyg. 92:1998;636-638.
17. Babad H.R., Nokes D.J., Gay N.J., Miller E., Morgan-Capner P., Anderson R.M. Predicting the impact of measles vaccination in England and Wales. model validation and analysis of policy options Epidemiol Infect. 114:1995;319-344.
18. Cutts F.T., Henao-Restrepo A.M., Olivé J.M. Measles elimination: progress and challenges. Vaccine. 17:1999;S47-S52.
19. Nokes D.J., Swinton J. Vaccination in pulses: a strategy for global eradication of measles and polio? Trends Microbiol. 5:1997;14-19.
20. Measles - progress towards global control and regional elimination, 1998-1999. Wkly Epidemiol Rec. 74:1999;429-440.
21. Cherry J.D. The 'new' epidemiology of measles and rubella. Hosp Pract. 15:1980;49-57.
22. Gustafson T.L., Lievens A.W., Brunell P.A.et al. Measles outbreak in a fully immunised secondary school population. N Engl J Med. 316:1987;771-774.
23. Kumate J. Infectious diseases in the 21st century. Arch Med Res. 28:1997;155-161.
24. Loutan L., Paillard S. Measles in a west African nomadic community. Bull World Health Organ. 70:1992;741-744.
25. Matzkin H., Regev S., Nili E. A measles outbreak in the Israel Defence Forces during the 1982 epidemic. Isr J Med Sci. 21:1985;351-355.
26. Hersh B.S., Markowitz L.E., Hoffman R.E.et al. A measles outbreak at a college with a prematriculation immunisation requirement. Am J Public Health. 81:1991;360-364.
27. Williams P.J., Hull H.F. Status of measles in Gambia, 1981. Rev Infect Dis. 5:1983;391-394.
28. Measles eradication: recommendations from a meeting cosponsored by the WHO, the Pan American Health Organization and CDC. MMWR CDC Surveill Summ. 46:1997;1-31.
29. Advances in global measles control and elimination: summary of the 1997 international meeting. MMWR CDC Surveill Summ. 47:1998;1-23.